PubMed Health⌕ Search

Biomedical subjects

M Zemlicka

Publications and source records attributed to M Zemlicka.

5 recordsLinked to original sources
PubMed2005

[Antioxidative activity of some over-the-counter plant extracts].

The recent years again saw increased interest of the public in the use of traditional natural remedies, such as plant extracts, for the treatment and prevention of diseases. This paper evaluates the antioxidative activity and content of phenolic substances of selected plant extracts from medicinal herbs, sold as dietary supplements with therapeutic effects. Using the production of 3-nitrotyrosine as the marker, the effects of extracts on the inhibition of peroxynitrite-induced nitration of tyrosine was examined, and the results were compared with the ability to extinguish the stable radical 2,2-diphenyl-1-picrylhydrazyl (DPPH). A linear correlation (r = 0.929) was found between the ability to extinguish DPPH and to inhibit tyrosine nitration. The found antioxidative activity ranged between values of 0-1702, or 0-1482 micromol of the catechine equivalent/100 ml of the extract. The total content of phenolic substances oscillated within values of 9.4-268.3 mg of the equivalent of gallic acid/100 ml of the extract. The significant linear relationship between antioxidative activities (r>0.9) and the total content of phenolic substances shows that phenolic substances are the principal group responsible for the antioxidative activity of the extracts tested.

Antioxidants↗
PubMed1994

[Radioprotective effects of basic copper carboxylate complexes].

The radioprotective activity of eight selected copper (II) carboxylates--Cu (RCOO)2.nL (R = alkyl, aryl, 2-furyl and 2-thienyl; L usually represents water)--was assayed in a model of lethally gamma-irradiated (9 Gy, 0.97 Gy/min) mice. The compounds tested were applied (as solutions in saline) s.c. in three single doses of 20 mumol/kg 48.24 and 6 h before irradiation. The highest radioprotective effects were measured by survival of mice achieved after premedication of animals with copper (II) 2-thenoate monohydrate (77%), copper (II) acetylsalicylate (64%), copper (II) 2-methoxybenzoate monohydrate (62%) and copper (II) acetate monohydrate (54%). On the other hand, survival of vehicle-pretreated mice was only 10%. The observed biological properties of complexes are discussed in relation to their structures.

Animals↗
PubMed1992

[Antimicrobial activity of selected aqua-carboxyl-cupric complexes].

The activity of compounds of different structural types of aqua-complexes of the composition Cu(R-COO)2.nH2O-methoxybenzoatocupric complexes, R = 2-, 3- and 4-methoxyphenyl (n = 1, 1 and 3); aryloxyacetatocupric complexes, R = phenoxymethyl (n = 3), 2-, 3- and 4-chlorophenoxymethyl (n = 4, 2 and 2) and 1-naphthoxymethyl (n = 4), and furthermore isomeric furanecarboxylato-(R = 2- or 3-furyl, n = 3, or 1) and thiophencarboxylatocupric complexes (R = 2- or 3-thienyl, n = 1 and 1), was examined by the methods of the 1st screening on selected anthropo- and phytopathogenic microorganisms. The effects of all aqua-complexes (suspension dosage form) on the representatives of bacteria and yeasts are minimal. On the other hand, the effect of these substances on the causative agents of dermatomycoses (Trichophyton terrestre, Microsporum gypseum) in the case of methoxybenzoato- and furoatocupric complexes achieves a MIC value of 500 micrograms/cm3 and lower. The activity against phytopathogenic fungi (both in vitro and in vivo experiments) is generally relatively low at 0.05% concentration of active ingredients (dispersible powders). At the same time the antimicrobial activity of the pertinent free carboxylic acids was investigated in relation to the cupric salts being formed. They are able to form the required pharmacoactive form prevalently as late as they are in the form of aqua-carboxylatocupric complexes.

Anti-Bacterial Agents↗